Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma

Figure 2

Efficacy variables of this study. Kaplan-Meier plots for efficacy variables analyzed for this study are presented: Median EFS (panel A), Median PFS (panel B), Median OS (panel C) and median TTR (panel D). Results are expressed in months. EFS= event-free survival; PFS= progression-free survival; OS= overall survival; TTR= time to tumor response.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us